Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
Markus Wallner, MD, PhD, FESC, FAHA, FHFAExpected completion time: 15 mins
0.25 CPD Credit
Late Breaking Clinical Trial - Presented at #ESC HF 2022
Sign up to start learning